RDGL — VIVOS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1449349 ·
Last close
$0.07
Market Cap
$34.42M
52W High
$0.09
52W Low
$0.06
ADV30
1,755,754
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 36,068 | -8,018 | -545,492 | -1,184,845 | 2,950,505 | 2,525,782 | 253,195 |
| Dec 2025 | 24,752 | -3,105 | -1,095,719 | -1,078,514 | 1,867,583 | 1,558,525 | 206,743 |
| Sep 2025 | 1,879 | -12,815 | -531,023 | -507,294 | 2,295,185 | 2,202,109 | 112,693 |
| Jun 2025 | 15,000 | -34,753 | -674,772 | -645,513 | 2,775,556 | 2,660,590 | 96,458 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,057,743
Investing CF
—
Financing CF
$1,506,905
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-88,427,246
Inventory
$57,257
Receivables
$22,331
ST Investments
—
EBIT TTM
$-3,165,046
Pretax Income TTM
$-3,066,017
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 68,379 | -3,165,047 | -3,066,017 | 1,867,583 | 206,743 | — | -2,057,743 |
| Dec 2024 | 27,995 | -2,604,384 | -2,910,448 | 2,233,456 | 86,209 | — | -1,684,039 |
| Dec 2023 | 19,500 | -2,793,146 | -2,894,753 | 1,610,124 | 245,004 | — | -1,293,023 |
| Dec 2022 | 36,499 | -2,517,749 | -2,470,161 | 1,742,736 | 81,692 | — | -1,120,058 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $33.36M | $3.87 | — |
| CODX | Co-Diagnostics, Inc. | $33.32M | $9.11 | — |
| MLSS | MILESTONE SCIENTIFIC INC. | $32.77M | $0.37 | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $36.42M | $1.20 | — |
| TELA | TELA Bio, Inc. | $36.44M | $0.81 | — |
News headlines (Yahoo Finance, 1h cache)
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
2026-05-20 20:10 · Yahoo
Vivos Therapeutics Reports Full Year 2025 Financial Results
2026-04-15 20:20 · Yahoo
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
2026-04-15 12:45 · Yahoo
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
2026-04-07 12:45 · Yahoo
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
2026-03-26 12:45 · Yahoo
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
2026-03-17 12:45 · Yahoo
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
2026-02-17 13:30 · Yahoo
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
2026-02-10 13:30 · Yahoo
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
2026-02-05 13:45 · Yahoo
Vivos Inc Updates Human Therapy Progress in India
2026-02-03 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.